12-114394817-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_181486.4(TBX5):c.587C>A(p.Ser196Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
TBX5
NM_181486.4 stop_gained
NM_181486.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.60
Genes affected
TBX5 (HGNC:11604): (T-box transcription factor 5) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is closely linked to related family member T-box 3 (ulnar mammary syndrome) on human chromosome 12. The encoded protein may play a role in heart development and specification of limb identity. Mutations in this gene have been associated with Holt-Oram syndrome, a developmental disorder affecting the heart and upper limbs. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-114394817-G-T is Pathogenic according to our data. Variant chr12-114394817-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 279906.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-114394817-G-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX5 | NM_181486.4 | c.587C>A | p.Ser196Ter | stop_gained | 6/9 | ENST00000405440.7 | NP_852259.1 | |
TBX5 | NM_000192.3 | c.587C>A | p.Ser196Ter | stop_gained | 6/9 | NP_000183.2 | ||
TBX5 | NM_080717.4 | c.437C>A | p.Ser146Ter | stop_gained | 5/8 | NP_542448.1 | ||
TBX5 | XM_017019912.2 | c.635C>A | p.Ser212Ter | stop_gained | 6/9 | XP_016875401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX5 | ENST00000405440.7 | c.587C>A | p.Ser196Ter | stop_gained | 6/9 | 1 | NM_181486.4 | ENSP00000384152 | P1 | |
TBX5 | ENST00000310346.8 | c.587C>A | p.Ser196Ter | stop_gained | 6/9 | 1 | ENSP00000309913 | P1 | ||
TBX5 | ENST00000349716.9 | c.437C>A | p.Ser146Ter | stop_gained | 5/8 | 1 | ENSP00000337723 | |||
TBX5 | ENST00000526441.1 | c.587C>A | p.Ser196Ter | stop_gained | 5/7 | 1 | ENSP00000433292 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Holt-Oram syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 10, 2021 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille | Jun 14, 2018 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 11, 2024 | Identified in additional patients with Holt-Oram syndrome in published literature (PMID: 16183809, 12789647, 10077612, 17534187); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25623069, 25525159, 34159885, 15710732, 8988164, 16183809, 25263169, 12789647, 10077612, 17534187) - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Jan 16, 2023 | - - |
Aortic valve disease 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change creates a premature translational stop signal (p.Ser196*) in the TBX5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBX5 are known to be pathogenic (PMID: 16183809, 16917909). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Holt-Oran syndrome (PMID: 8988164, 10077612, 12789647, 15710732, 17534187). This variant is also known as c.1243C>A. ClinVar contains an entry for this variant (Variation ID: 279906). For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.587C>A (p.S196*) alteration, located in exon 6 (coding exon 5) of the TBX5 gene, consists of a C to A substitution at nucleotide position 587. This changes the amino acid from a serine (S) to a stop codon at amino acid position 196. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant was reported in multiple individuals with features consistent with Holt-Oram syndrome (Basson, 1999; Brassington, 2003; McDermott, 2005; Debeer, 2007) and has been determined to be the result of a de novo mutation or germline mosaicism in two families (Li, 1997; Sobh, 2022). Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
A;A;A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at